FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W320841108> ?p ?o ?g. }

• W320841108 endingPage "1675" @default.
• W320841108 startingPage "1666" @default.
• W320841108 abstract "The multivariate nature of cancer necessitates multi-targeted therapy, and kinase inhibitors account for a vast majority of approved cancer therapeutics. While acute promyelocytic leukemia (APL) patients are highly responsive to retinoic acid (RA) therapy, kinase inhibitors have been gaining momentum as co-treatments with RA for non-APL acute myeloid leukemia (AML) differentiation therapies, especially as a means to treat relapsed or refractory AML patients. In this study GW5074 (a c-Raf inhibitor) and PP2 (a Src-family kinase inhibitor) enhanced RA-induced maturation of t(15;17)-negative myeloblastic leukemia cells and rescued response in RA-resistant cells. PD98059 (a MEK inhibitor) and Akti-1/2 (an Akt inhibitor) were less effective, but did tend to promote maturation-uncoupled G1/G0 arrest, while wortmannin (a PI3K inhibitor) did not enhance differentiation surface marker expression or growth arrest. PD98059 and Akti-1/2 did not enhance differentiation markers and have potential, antagonistic off-targets effects on the aryl hydrocarbon receptor (AhR), but neither could the AhR agonist 6-formylindolo(3,2-b)carbazole (FICZ) rescue differentiation events in the RA-resistant cells. GW5074 rescued early CD38 expression in RA-resistant cells exhibiting an early block in differentiation before CD38 expression, while for RA-resistant cells with differentiation blocked later, PP2 rescued the later differentiation marker CD11b; but surprisingly, the combination of the two was not synergistic. Kinases c-Raf, Src-family kinases Lyn and Fgr, and PI3K display highly correlated signaling changes during RA treatment, while activation of traditional downstream targets (Akt, MEK/ERK), and even the surface marker CD38, were poorly correlated with c-Raf or Lyn during differentiation. This suggests that an interrelated kinase module involving c-Raf, PI3K, Lyn and perhaps Fgr functions in a nontraditional way during RA-induced maturation or during rescue of RA induction therapy using inhibitor co-treatment in RA-resistant leukemia cells." @default.
• W320841108 created "2016-06-24" @default.
• W320841108 creator A5003161155 @default.
• W320841108 creator A5027126263 @default.
• W320841108 creator A5027960117 @default.
• W320841108 creator A5032779286 @default.
• W320841108 date "2015-08-01" @default.
• W320841108 modified "2023-09-29" @default.
• W320841108 title "GW5074 and PP2 kinase inhibitors implicate nontraditional c-Raf and Lyn function as drivers of retinoic acid-induced maturation" @default.
• W320841108 cites W1504562963 @default.
• W320841108 cites W1587753655 @default.
• W320841108 cites W1658415069 @default.
• W320841108 cites W1675086682 @default.
• W320841108 cites W182996286 @default.
• W320841108 cites W1903161793 @default.
• W320841108 cites W1955568895 @default.
• W320841108 cites W1961530921 @default.
• W320841108 cites W1965133242 @default.
• W320841108 cites W1967585026 @default.
• W320841108 cites W1969047667 @default.
• W320841108 cites W1971727526 @default.
• W320841108 cites W1972602773 @default.
• W320841108 cites W1972811295 @default.
• W320841108 cites W1979187651 @default.
• W320841108 cites W1982338224 @default.
• W320841108 cites W1983971021 @default.
• W320841108 cites W1984485912 @default.
• W320841108 cites W1988317806 @default.
• W320841108 cites W1995083340 @default.
• W320841108 cites W2002393876 @default.
• W320841108 cites W2004295816 @default.
• W320841108 cites W2012753533 @default.
• W320841108 cites W2014161058 @default.
• W320841108 cites W2021620348 @default.
• W320841108 cites W2022360690 @default.
• W320841108 cites W2025876684 @default.
• W320841108 cites W2027044879 @default.
• W320841108 cites W2029804363 @default.
• W320841108 cites W2034990900 @default.
• W320841108 cites W2039853192 @default.
• W320841108 cites W2041414354 @default.
• W320841108 cites W2042834671 @default.
• W320841108 cites W2043306142 @default.
• W320841108 cites W2043859776 @default.
• W320841108 cites W2046822015 @default.
• W320841108 cites W2047227933 @default.
• W320841108 cites W2049949265 @default.
• W320841108 cites W2050349481 @default.
• W320841108 cites W2051165598 @default.
• W320841108 cites W2053650018 @default.
• W320841108 cites W2054292493 @default.
• W320841108 cites W2056313155 @default.
• W320841108 cites W2058640030 @default.
• W320841108 cites W2065332363 @default.
• W320841108 cites W2077452823 @default.
• W320841108 cites W2079483713 @default.
• W320841108 cites W2087993777 @default.
• W320841108 cites W2093481931 @default.
• W320841108 cites W2097298305 @default.
• W320841108 cites W2110487056 @default.
• W320841108 cites W2133168488 @default.
• W320841108 cites W2133540186 @default.
• W320841108 cites W2136075582 @default.
• W320841108 cites W2141010709 @default.
• W320841108 cites W2144474266 @default.
• W320841108 cites W2148156146 @default.
• W320841108 cites W2149662085 @default.
• W320841108 cites W2153404441 @default.
• W320841108 cites W2156928849 @default.
• W320841108 cites W2157107922 @default.
• W320841108 cites W2159159025 @default.
• W320841108 cites W2159178827 @default.
• W320841108 cites W2159664830 @default.
• W320841108 cites W2163758751 @default.
• W320841108 cites W2169987792 @default.
• W320841108 cites W2172677241 @default.
• W320841108 cites W2333011916 @default.
• W320841108 cites W2409277110 @default.
• W320841108 cites W4231860860 @default.
• W320841108 doi "https://doi.org/10.1016/j.cellsig.2015.03.014" @default.
• W320841108 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4529126" @default.
• W320841108 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25817574" @default.
• W320841108 hasPublicationYear "2015" @default.
• W320841108 type Work @default.
• W320841108 sameAs 320841108 @default.
• W320841108 citedByCount "12" @default.
• W320841108 countsByYear W3208411082016 @default.
• W320841108 countsByYear W3208411082017 @default.
• W320841108 countsByYear W3208411082018 @default.
• W320841108 countsByYear W3208411082019 @default.
• W320841108 crossrefType "journal-article" @default.
• W320841108 hasAuthorship W320841108A5003161155 @default.
• W320841108 hasAuthorship W320841108A5027126263 @default.
• W320841108 hasAuthorship W320841108A5027960117 @default.
• W320841108 hasAuthorship W320841108A5032779286 @default.
• W320841108 hasBestOaLocation W3208411081 @default.
• W320841108 hasConcept C10205521 @default.
• W320841108 hasConcept C104317684 @default.

• next